Found: 9
Select item for more details and to access through your institution.
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133 (+) Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prevention of West Nile virus transmission by blood transfusion: a comparison of nucleic acid test screening assays.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators.
- Published in:
- Transfusion, 2004, v. 44, n. 1, p. 125, doi. 10.1046/j.0041-1132.2004.00613.x
- By:
- Publication type:
- Article
GMP-based CD133<sup>+</sup> cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.
- Published in:
- Journal of Cellular & Molecular Medicine, 2010, v. 14, n. 6b, p. 1619, doi. 10.1111/j.1582-4934.2009.00854.x
- By:
- Publication type:
- Article
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.
- Published in:
- 2020
- By:
- Publication type:
- journal article
MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial.
- Published in:
- Intensive Care Medicine Experimental, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40635-023-00535-1
- By:
- Publication type:
- Article
Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133<sup>+</sup> cells in ischemic refractory cardiomyopathy trial (RECARDIO).
- Published in:
- Stem Cell Research & Therapy, 2018, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13287-018-0969-z
- By:
- Publication type:
- Article
Congenital Absence of the Inferior Vena Cava and Genetic Coagulation Abnormalities: A Rare Associated Risk Factor for Recurrent Idiopathic Deep Vein Thrombosis.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2003, v. 9, n. 4, p. 347, doi. 10.1177/107602960300900412
- By:
- Publication type:
- Article